ArticleOncotarget2016

Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.

Kelli L Goss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.